Immunity against seasonal human coronavirus OC43 mitigates fatal deterioration of COVID-19

BACKGROUND: The effects of high-intensity immunity on coronavirus disease 2019 (COVID-19) remain unclear. Antibodies against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) are preferentially induced in inpatients with COVID-19 compared with outpatients with milder disease, and immunosu...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamaguchi, Tomoyuki, Shinagawa, Toshie, Kobata, Hisanobu, Nakagawa, Hidemitsu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278827/
https://www.ncbi.nlm.nih.gov/pubmed/34273512
http://dx.doi.org/10.1016/j.ijid.2021.07.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278827/
https://www.ncbi.nlm.nih.gov/pubmed/34273512
http://dx.doi.org/10.1016/j.ijid.2021.07.015

Ejemplares similares